Literature DB >> 16139819

Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.

Boris B Quednow1, Michael Wagner, Jens Westheide, Katrin Beckmann, Niclaas Bliesener, Wolfgang Maier, Kai-Uwe Kühn.   

Abstract

BACKGROUND: Schizophrenic patients exhibit impairments in prepulse inhibition (PPI) and habituation of the acoustic startle response (ASR). Recent studies suggested that PPI deficits and habituation deficits are normalized after antipsychotic treatment. Despite clear evidence of gating and habituation mechanisms in animal models, it is still unknown which neurotransmitter systems are involved in schizophrenic patients. Thus, we compared the effects of a combined 5-HT2A/D2 and a pure D2/D3 antagonist on PPI and habituation of ASR in patients with schizophrenia.
METHODS: The ASR was measured in 37 acute schizophrenic patients who were randomized and double-blinded as to treatment with amisulpride or olanzapine. Patients were assessed during the first week and after four and eight weeks of treatment. Twenty healthy matched control subjects were examined likewise.
RESULTS: Schizophrenic patients showed a significant PPI deficit and significantly decreased startle amplitude at baseline. The gating deficit disappeared after antipsychotic treatment in both treatment groups. Amisulpride sensitized the startle amplitude, whereas startle amplitude was not changed by olanzapine. After correcting for startle amplitude, patients did not show a habituation deficit; however, amisulpride accelerated habituation, whereas olanzapine had no effect.
CONCLUSIONS: Our findings suggest that the PPI-restoring effect of antipsychotics is probably attributed to a dopamine D2 receptor blockade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139819     DOI: 10.1016/j.biopsych.2005.07.012

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  38 in total

Review 1.  Impact of TCF4 on the genetics of schizophrenia.

Authors:  Leonhard Lennertz; Boris B Quednow; Jens Benninghoff; Michael Wagner; Wolfgang Maier; Rainald Mössner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-20       Impact factor: 5.270

2.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating.

Authors:  Erin A Hazlett; Monte S Buchsbaum; Jing Zhang; Randall E Newmark; Cathryn F Glanton; Yuliya Zelmanova; M Mehmet Haznedar; King-Wai Chu; Igor Nenadic; Eileen M Kemether; Cheuk Y Tang; Antonia S New; Larry J Siever
Journal:  Neuroimage       Date:  2008-07-11       Impact factor: 6.556

4.  Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.

Authors:  Signe Düring; Birte Y Glenthøj; Gitte Saltoft Andersen; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2014-07-23       Impact factor: 7.853

5.  Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS.

Authors:  Neal R Swerdlow; Gregory A Light; Joyce Sprock; Monica E Calkins; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Allen D Radant; Amrita Ray; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Res       Date:  2014-01-07       Impact factor: 4.939

6.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

7.  The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions.

Authors:  Natalia I Brzozowska; Erik J de Tonnerre; Kong M Li; Xiao Suo Wang; Aurelie A Boucher; Paul D Callaghan; Michael Kuligowski; Alex Wong; Jonathon C Arnold
Journal:  Neuropsychopharmacology       Date:  2017-03-08       Impact factor: 7.853

8.  Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.

Authors:  Kathy L Kohlhaas; Robert S Bitner; Murali Gopalakrishnan; Lynne E Rueter
Journal:  Psychopharmacology (Berl)       Date:  2011-10-29       Impact factor: 4.530

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 10.  From genes to psychoses and back: the role of the 5HT2alpha-receptor and prepulse inhibition in schizophrenia.

Authors:  Wolfgang Maier; Rainald Mössner; Boris B Quednow; Michael Wagner; René Hurlemann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.